VRDN SG&A Expense Growth
Viridian Therapeutics Ors Inc · SG&A Expense Growth
VRDN SG&A Expense Growth
Latest reported56.04%period ending
VRDN FY SG&A Growth (YoY) (0.00% → 56.04%)
Latest values, visible window
High-resolution chart · PNG
VRDN sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 56.0418% | |
| -35.7014% | |
| 170.0216% | |
| 36.3379% | |
| 94.5345% | |
| 13.9018% | |
| 5.4032% | |
| 1.2555% | |
| 13.9634% | |
| -6.5945% | |
| 32.2539% | |
| 257.6983% | |
| -48.8114% | |
| 0% |